Warfarin utilization and stroke risk in patients with chronic non-valvular atrial fibrillation

被引：0
|
作者：
Boccuzzi, SJ
Stephenson, JJ
Kreilick, CA
Beaulieu, JF
Hauch, O
Kim, J
机构：
[1] Aetna Hlth Informat Solut, Blue Bell, PA USA
[2] AstraZeneca LP, Wilmington, DE USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：335A / 335A
页数：1
相关论文
共 50 条
  • [1] WARFARIN DISCONTINUATION AND STROKE RISK AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A8 - A9
  • [2] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [3] Ischemic Stroke and Bleeding Risk in Patients with Non-valvular Atrial Fibrillation Treated with Warfarin
    He, S. B.
    Yu, S. H.
    Meng, R.
    Ru, S. W.
    Gong, Z. J.
    Liu, H. M.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S406 - S406
  • [4] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [5] Impact of stroke risk factors on warfarin prescription among patients with non-valvular atrial fibrillation
    Zhao, Yu-Hui
    Zhang, Ting
    Du, Xin
    Wen, Dan
    Shang, Mei-Sheng
    Ma, Chang-Sheng
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (08): : 16587 - 16595
  • [6] A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients
    Song, Ziliang
    Xu, Kai
    Hu, Xiaofeng
    Jiang, Weifeng
    Wu, Shaohui
    Qin, Mu
    Liu, Xu
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [7] STROKE PROPHYLAXIS WITH WARFARIN AND DABIGATRAN FOR PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION - A COST ANALYSIS
    Ali, A. N.
    Bailey, C.
    Abdulhafiz, A. H.
    [J]. AGE AND AGEING, 2013, 42 : 31 - 31
  • [8] Stroke prevention in non-valvular atrial fibrillation: Can warfarin do better?
    Apostolakis, Stavros
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (05) : 753 - 754
  • [9] Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis
    Ali, Ali
    Bailey, Claire
    Abdelhafiz, Ahmed H.
    [J]. AGE AND AGEING, 2012, 41 (05) : 681 - 684
  • [10] Stroke and bleeding with NOAC and warfarin in patients with non-valvular atrial fibrillation in the Stockholm healthcare system
    Forslund, T.
    Wettermark, B.
    Hjemdahl, P.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 792 - 792
12345